Announcements
On 6 June 2017, the World Health Organization (WHO) published updates to its ‘Essential Medicines List’ (EML). Read more here.

Extended deadline (from 1 July to 31 July) 2017 for call to submit papers on effectiveness and cost-effectiveness of screening and prevention of infectious diseases among newly arrived migrants in Europe. Read more here.

Eurosurveillance is on the updated list of the Directory of Open Access Journals and in the SHERPA/RoMEO database. Read more here.

Follow Eurosurveillance on Twitter: @Eurosurveillanc


In this issue


Home Eurosurveillance Edition  2017: Volume 22/ Issue 10 Article 4
Back to Table of Contents
Previous Download (pdf)

Eurosurveillance, Volume 22, Issue 10, 09 March 2017
News
Eurosurveillance editorial team: WHO recommendations on the composition of the 2017/18 influenza virus vaccines in the northern hemisphere

+ Author affiliations


Citation style for this article: Eurosurveillance editorial team. WHO recommendations on the composition of the 2017/18 influenza virus vaccines in the northern hemisphere. Euro Surveill. 2017;22(10):pii=30479. DOI: http://dx.doi.org/10.2807/1560-7917.ES.2017.22.10.30479


On 2 March 2017, the World Health Organization (WHO) published recommendations on the composition of the trivalent and quadrivalent vaccines for the 2017/18 northern hemisphere influenza season [1]. WHO recommends that trivalent vaccines for use in the 2017/18 northern hemisphere influenza season contain the following:

  • an A/Michigan/45/2015 (H1N1)pdm09-like virus;

  • an A/Hong Kong/4801/2014 (H3N2)-like virus; and

  • a B/Brisbane/60/2008-like virus.

For the quadrivalent vaccines containing two influenza B viruses, WHO recommends that they contain the above three viruses and a B/Phuket/3073/2013-like virus.

As in previous years, national or regional authorities approve the composition and formulation of vaccines used in each country. National public health authorities are responsible for making recommendations regarding the use of the vaccine.

WHO organises consultations with an advisory group of experts twice every year to analyse influenza virus surveillance data generated by the WHO Global Influenza Surveillance and Response System (GISRS), and issues recommendations on the composition of the influenza vaccines for the following influenza season.



References

  1. World Health Organization (WHO). Recommended composition of influenza virus vaccines for use in the 2017-2018 northern hemisphere influenza season. Geneva: WHO; Mar 2017. Available from: http://www.who.int/influenza/vaccines/virus/recommendations/201703_recommendation.pdf?ua=1



Back to Table of Contents
Previous Download (pdf)

The publisher’s policy on data collection and use of cookies.

Disclaimer: The opinions expressed by authors contributing to Eurosurveillance do not necessarily reflect the opinions of the European Centre for Disease Prevention and Control (ECDC) or the editorial team or the institutions with which the authors are affiliated. Neither ECDC nor any person acting on behalf of ECDC is responsible for the use that might be made of the information in this journal. The information provided on the Eurosurveillance site is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician. Our website does not host any form of commercial advertisement. Except where otherwise stated, all manuscripts published after 1 January 2016 will be published under the Creative Commons Attribution (CC BY) licence. You are free to share and adapt the material, but you must give appropriate credit, provide a link to the licence, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.

Eurosurveillance [ISSN] - ©2007-2016. All rights reserved
 

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.